Timothy W Patrick

Timothy W. Patrick serves as a Contract Specialist with Network Contract Office 23 (36C263) under the Department of Veterans Affairs, where he plays a pivotal role in executing procurements critical to sustaining VA healthcare delivery nationwide. He manages the full lifecycle of acquisitions for high-acuity medical equipment, surgical supplies, and electromedical devices, ensuring compliance with federal regulations and VA clinical standards. His work directly supports the operational readiness of VA medical facilities by securing reliable, FDA-compliant technologies essential for patient care, including diagnostic and therapeutic systems used in surgical and intensive care environments. Patrick maintains consistent contracting relationships with a core group of established vendors, including Abbott Laboratories Inc., Primary Care Solutions Inc., and BZ Construction and Development LLC, reflecting a preference for proven suppliers with demonstrated capability in medical manufacturing and facility infrastructure. His partnerships are characterized by long-term reliability and technical alignment with VA’s clinical requirements, often involving complex solicitation strategies such as performance-based service contracts and blanket purchase agreements to ensure continuity of supply. His procurement portfolio exhibits no set-aside preferences, with 100% of awards issued under full and open competition. This reflects a strategic focus on technical superiority, regulatory compliance, and supply chain resilience over socioeconomic categorizations, prioritizing mission-critical performance over socioeconomic criteria. Patrick’s expertise is concentrated in NAICS 339113 (Surgical Appliance and Supplies Manufacturing), which accounts for nearly all of his acquisitions, alongside minor activity in biological product manufacturing (325414) and electromedical apparatus manufacturing (334510). He specializes in procuring sterile surgical kits, implantable devices, and advanced electrotherapeutic equipment, demonstrating deep familiarity with FDA Class II/III medical device regulations and clinical procurement protocols governing high-risk healthcare technologies.